Maybe the next ones will pump more money into HM (wishful thinking). Most likely they’ll try and expand their wig business. >:-(
http://www.bloomberg.com/apps/news?pid=20601101&sid=aM_2Uu4JuSGA&refer=japan
One can only hope that this highly public change in leadership at ARI’s parent company, Aderan’s - which was influenced by a US-based hedgefund company - will bring a more progressive mindset to the Aderan’s business model and switch its focus from wigs to an increased focus on regenerative cell therapy, including a possible acquisition of Intercytex’s technolgy, which is currently in a holding pattern.
May be the R&D department was a failure which it seems obvious to our community. If that’s the case it’s possible that the new board will be reluctant to invest more money in what caused the ousting of the previous one…It’s just an assumption , hope I’m wrong.